These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38564432)

  • 21. Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21-years prospective study from a single institution.
    Avilés-Izquierdo JA; Nieto-Benito LM; Lázaro-Ochaita P; Escat-Cortés JL; Marquez-Rodas I; Mercader-Cidoncha E
    Clin Transl Oncol; 2020 Sep; 22(9):1611-1618. PubMed ID: 32065344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
    Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
    Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Mitotic Rate Predicts Sentinel Lymph Node Involvement in Thin Melanomas.
    Skochdopole AJ; Kutlu OC; Engelhardt KE; Lancaster WP; Abbott AM; Camp ER
    J Surg Res; 2020 Dec; 256():198-205. PubMed ID: 32711176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
    Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR
    J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node biopsy in Merkel cell carcinoma: Predictors of sentinel lymph node positivity and association with overall survival.
    Conic RRZ; Ko J; Saridakis S; Damiani G; Funchain P; Vidimos A; Gastman BR
    J Am Acad Dermatol; 2019 Aug; 81(2):364-372. PubMed ID: 30902726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
    Bello DM; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases.
    Kakavand H; Vilain RE; Wilmott JS; Burke H; Yearley JH; Thompson JF; Hersey P; Long GV; Scolyer RA
    Mod Pathol; 2015 Dec; 28(12):1535-44. PubMed ID: 26403784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires.
    Nardi WS; Toffolo Pasquini M; Tomé F; Vigovich F; Cora MF; Quildrian SD
    Medicina (B Aires); 2024; 84(2):279-288. PubMed ID: 38683513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of tumor infiltrating lymphocytes in melanoma.
    Burton AL; Roach BA; Mays MP; Chen AF; Ginter BA; Vierling AM; Scoggins CR; Martin RC; Stromberg AJ; Hagendoorn L; McMasters KM
    Am Surg; 2011 Feb; 77(2):188-92. PubMed ID: 21337878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel node tumor burden in cutaneous melanoma. Survival with competing risk analysis and influence in relapses and non-sentinel node status: retrospective cohort study with long follow-up in a Spanish population.
    Loidi-Pascual L; Librero J; Córdoba-Iturriagagoitia A; Guarch-Troyas R; Montes-Díaz M; Ruiz de Azua-Ciria Y; Arozarena I; Goñi-Gironés E; Yanguas I
    Arch Dermatol Res; 2022 May; 314(4):369-378. PubMed ID: 33973061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for sentinel lymph node metastasis in Korean acral and non-acral melanoma patients.
    Song JY; Ryu YJ; Lee HK; Lee DH; Choi YD; Shim HJ; Yun SJ
    Pigment Cell Melanoma Res; 2024 May; 37(3):332-342. PubMed ID: 38013393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T regulatory cells mediate immunosuppresion by adenosine in peripheral blood, sentinel lymph node and TILs from melanoma patients.
    Di Gennaro P; Gerlini G; Caporale R; Sestini S; Brandani P; Urso C; Pimpinelli N; Borgognoni L
    Cancer Lett; 2018 Mar; 417():124-130. PubMed ID: 29306022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center.
    Namikawa K; Aung PP; Gershenwald JE; Milton DR; Prieto VG
    Cancer Med; 2018 Mar; 7(3):583-593. PubMed ID: 29464914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
    Sinnamon AJ; Song Y; Sharon CE; Yang YX; Elder DE; Zhang PJ; Xu X; Roses RE; Kelz RR; Fraker DL; Karakousis GC
    Ann Surg Oncol; 2018 Nov; 25(12):3469-3475. PubMed ID: 30043316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexistence of regression and tumor infiltrating lymphocytes is associated with more favorable survival in melanoma.
    Tas F; Erturk K
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2721-2729. PubMed ID: 33611652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Role of Multiple Lymphatic Basin Drainage in Sentinel Lymph Node-Negative Trunk Melanoma Patients: A Multicenter Study from the Italian Melanoma Intergroup.
    Ribero S; Osella-Abate S; Pasquali S; Rossi CR; Borgognoni L; Piazzalunga D; Solari N; Schiavon M; Brandani P; Ansaloni L; Ponte E; Silan F; Sommariva A; Bellucci F; Macripò G; Quaglino P
    Ann Surg Oncol; 2016 May; 23(5):1708-15. PubMed ID: 26597362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.